The pharmaceutical market in South Korea will rise from approximately $18.6 billion in 2016 to $20.4 billion in 2020, representing a compound annual growth rate (CAGR) of 2.4%. The Korean government is encouraging Research and Development (R&D) and sustaining growth initiatives in the pharmaceutical industry, such as the Korean Small Business Innovation Research program.
With 4,537 attendees from 51 countries attending the 2016 show, CPhI Korea provides the ideal platform to gain insights and do business with decision makers in the regional market. The exhibition is a key opportunity for you to accomplish months of business with these key decision makers over just a few days. With a high focus on the local market, the 2016 event saw participation of the leading Korean pharma companies, with decision makers covering R&D, business development and sales and marketing.
What our exhibitors say
“We could engage the buyers’ attention by showcasing our big machineries and it was a good brand marketing tool. Especially, lots of overseas buyers have visited our booth so CPhI Korea 2016 was a perfect opportunity to increase our brand awareness in overseas markets.”
Mr. Jung-Sik Ye, General Manager, Daeyong Pharmatech
“ We could see many more buyers compared to last year, and especially, it was good to meet the buyers from surrounding Asia regions such as China, Japan, Iran, and Turkey. Next to that, it was very effective to showcase our new products and technology to domestic traders and buyers. ”
Ms. Shruti Kutariyar & Mr. Virash R. Maurya
Sr. Executive Marketing, Harman Finochem
“It was really nice to have so many meetings and get to know some companies with high productivity through the online matchmaking system. Also, it was really great to meet many overseas buyers especially from Asia and Middle Eastern regions.”
Mr. Eun-Hyong Lee, Overseas Business Department Manager, Daewon Pharm
CPhI Korea is the Korean marketplace for pharmaceutical ingredients buyers, manufacturers and suppliers. It represents all aspects of the ingredients market, including APIs, fine chemicals, biopharmaceuticals, excipients/formulation, intermediates, generic APIs, finished dosage and custom manufacturing.
ICSE Korea connects the global pharmaceutical community with Korean outsourcing solutionproviders, including clinical trials, contract research, custom manufacturing, biotechnology, IT, analytical services, packaging services and logistics.
P-MEC Korea brings together the global and Korean pharmaceutical machinery and equipment providers including analytical equipment, automation & robotics, cleanroom equipment, filtration / separation / purification, plant / facility equipment, processing equipment, RFID and validation.
BioPh Korea focuses onbiotechnology and related fields offering an ideal platform for biopharma companies, drug discovery organisations, pharma manufacturers and scientific research institutions to create new partnerships and discuss the latest trends with representatives from all areas of biotech and genetic engineering.
Hi Korea is a global meeting place for worldwide health ingredients manufacturers, traders, service providers, and other related professionals. Including: Health/Natural/Functional/Bio Ingredients, Functional food additives, Food technology/equipment, and conract manufacturing.
Exhibitors at CPhI Korea in 2016 were active in sectors including:
- Generic APIs
Exhibitors at ICSE, P-MEC and BioPh include:
- Contract services
- Technology and machinery
Want to book a stand?
By securing your exhibition space early you gain a number of significant benefits, including first choice of stand positions and visibility on our website as an exhibitor.
You can choose between the exhibition packages, depending on your requirements. Full stand options will be available soon.